Marinus Pharmaceuticals Inc (MRNS) Return on Investment ROI from the third quarter of 2024 to third quarter of 2023 and for the year 2024, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Marinus Pharmaceuticals Inc   (NASDAQ: MRNS)


Marinus Pharmaceuticals Inc's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Marinus Pharmaceuticals Inc's ROI in the third quarter of 2024?
Marinus Pharmaceuticals Inc recorded a cumulative net loss of $-140 million during 12 months ending in the third quarter of 2024, resulting in a negative return on investment (ROI) of -221.23%.

Within the Healthcare sector 837 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2024 from 2908 to 4539.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Investment Change TTM -67.39 % -49.53 % -23.56 % 7.92 % 77.22 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 29 51 95 79 164
Return On Investment (TTM) -221.23 % -153.67 % -113.36 % -90.71 % -67.93 %
MRNS's Overall Ranking # 4539 # 2908 # 3215 # 4056 #
Seq. Investment Change TTM -34.61 % -24.25 % -17.75 % -19.95 % 1.21 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -140 -149 -145 -141 -132

MRNS Company Profile >> Back to MRNS Roi Comparisons >> See Annual MRNS Return On Investment



Return On Investment MRNS's Ranking
Within: No.
Industry # 402
Sector # 838
Overall # 4539

Return On Investment Statistics
High Average Low
-12.74 %
-97.76 %
-1189.64 %
(Dec 31 2022)   (Dec 31 2014)







Financial Statements
Marinus Pharmaceuticals Inc's III. Quarter Investments $ 29 Millions MRNS's Balance sheet
Marinus Pharmaceuticals Inc's III. Quarter Income $ -24 Millions Quarterly MRNS's Income Statement
MRNS's Income by Division See MRNS's Income by Division


MRNS Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 79 235 96 140 91
Y / Y Investment Growth -66.27 % 143.58 % -31.1 % 53.87 % 32.91 %
Net Income in Millions -141 -20 -99 -67 -54
Y / Y Net Income Growth - - - - -
Annual Return On Investment -178.79 % -8.45 % -102.6 % -48.29 % -59.6 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MRNS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MRNS's Competitors
Subscribers only: Roi for Marinus Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for MRNS's Customers

Other Ratios
MRNS's Roa MRNS's Inventory Turnover Ratio MRNS's Growth Rates MRNS's Dividend Statistics
MRNS's Profitability Ratios MRNS's Asset Turnover Ratio MRNS's Dividend Growth
MRNS's Roe MRNS's Valuation Ratios MRNS's Financial Strength Ratios MRNS's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-26T07:02:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.